Skip to main content
Clinical Trials/DRKS00007105
DRKS00007105
Completed
未知

Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology - FOXPRO

Klinik für Urologie, Universitätsmedizin Mannheim0 sites50 target enrollmentNovember 4, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
C61
Sponsor
Klinik für Urologie, Universitätsmedizin Mannheim
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2014
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Klinik für Urologie, Universitätsmedizin Mannheim

Eligibility Criteria

Inclusion Criteria

  • Serum PSA: PSA \< 10 ng/ml
  • mpMRT/TRUS bioptic proven prostate cancer:
  • \- Clinical stage: T1c, unifocal
  • \- Gleason score \= 3 \+ 4
  • Life expectancy \> 10 yr

Exclusion Criteria

  • Previous treatment:
  • Previous treatment of the primary cancer within the prostate
  • Previous hormone treatment for prostate cancer within 6 months before trial
  • Previous radiation to pelvis
  • Active urinary tract infection
  • One or more of the following findings in multiparametric MRI:
  • PI\-RADS score \< 3 of the treatment lesion
  • PI\-RADS score \> 3 of opposite site
  • Extracapsular extension or seminal vesicle invasion

Outcomes

Primary Outcomes

Not specified

Similar Trials